Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer

Published:2018-08-15 Issue:6 Volume:122 Page:970-977
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Elliott Daisy¹^ORCID,Hamdy Freddie C.²,Leslie Tom A.²,Rosario Derek³,Dudderidge Tim⁴,Hindley Richard⁵,Emberton Mark⁶^ORCID,Brewster Simon²,Sooriakumaran Prasanna⁷,Catto James W.F.³,Emara Amr⁵,Ahmed Hashim⁸,Whybrow Paul¹,le Conte Steffi²,Donovan Jenny L.¹⁹

Affiliation:

1. Population Health Sciences; Bristol Medical School; University of Bristol; Bristol UK

2. Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

3. Department of Oncology and Metabolism; University of Sheffield; Sheffield UK

4. University Hospital Southampton NHS Foundation Trust; Southampton UK

5. Hampshire Hospitals NHS Foundation Trust; Basingstoke UK

6. Division of Surgery and Interventional Science; University College London; London UK

7. University College London Hospital NHS Foundation Trust; London UK

8. Imperial Urology; Imperial College Healthcare NHS Trust; London UK

9. NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust; Bristol UK

Funder

Health Technology Assessment Programme

Medical Research Council

Wellcome Trust

Prostate Cancer UK

National Institute for Health Research

Sophiris Inc.

Sonacare Inc.

Trod Medical

UCLH/UCL NIHR Biomedical Research Centre

Collaboration for Leadership in Applied Health Research and Care

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14432/fullpdf

Reference19 articles.

1. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. New and established technology in focal ablation of the prostate: a systematic review;Valerio;Eur Urol,2017

3. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation;Ramsay;Health Technol Assess,2015

4. Can we deliver randomized trials of focal therapy in prostate cancer?;Ahmed;Nat Rev Clin Oncol,2014

5. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI);Donovan;Trials,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study;BMJ Open;2024-05

2. Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control;European Urology Focus;2024-04

3. The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN project;BMC Medical Research Methodology;2023-11-11

4. Health care professional recruitment of patients and family carers to palliative care randomised controlled trials: A qualitative multiple case study;Palliative Medicine;2023-09-27

5. Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience;Journal of Urology;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3